Loss of ubiquitin-specific peptidase 18 destabilizes 14-3-3ζ protein and represses lung cancer metastasis

Cancer metastasis is a major cause of cancer-related mortality. Strategies to reduce metastases are needed especially in lung cancer, the most common cause of cancer mortality. We previously reported increased ubiquitin-specific peptidase 18 (USP18) expression in lung and other cancers. Engineered r...

Full description

Bibliographic Details
Main Authors: Zibo Chen, Lin Zheng, Yulong Chen, Xiuxia Liu, Masanori Kawakami, Lisa Maria Mustachio, Jason Roszik, Katherine V. Ferry-Galow, Ralph E. Parchment, Xin Liu, Thorkell Andresson, Gerard Duncan, Jonathan M. Kurie, Jaime Rodriguez-Canales, Xi Liu, Ethan Dmitrovsky
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Cancer Biology & Therapy
Subjects:
Online Access:http://dx.doi.org/10.1080/15384047.2022.2054242
_version_ 1797404053891710976
author Zibo Chen
Lin Zheng
Yulong Chen
Xiuxia Liu
Masanori Kawakami
Lisa Maria Mustachio
Jason Roszik
Katherine V. Ferry-Galow
Ralph E. Parchment
Xin Liu
Thorkell Andresson
Gerard Duncan
Jonathan M. Kurie
Jaime Rodriguez-Canales
Xi Liu
Ethan Dmitrovsky
author_facet Zibo Chen
Lin Zheng
Yulong Chen
Xiuxia Liu
Masanori Kawakami
Lisa Maria Mustachio
Jason Roszik
Katherine V. Ferry-Galow
Ralph E. Parchment
Xin Liu
Thorkell Andresson
Gerard Duncan
Jonathan M. Kurie
Jaime Rodriguez-Canales
Xi Liu
Ethan Dmitrovsky
author_sort Zibo Chen
collection DOAJ
description Cancer metastasis is a major cause of cancer-related mortality. Strategies to reduce metastases are needed especially in lung cancer, the most common cause of cancer mortality. We previously reported increased ubiquitin-specific peptidase 18 (USP18) expression in lung and other cancers. Engineered reduction of USP18 expression repressed lung cancer growth and promoted apoptosis. This deubiquitinase (DUB) stabilized targeted proteins by removing the complex interferon-stimulated gene 15 (ISG15). This study explores if the loss of USP18 reduced lung cancer metastasis. USP18 knock-down in lung cancer cells was independently achieved using small hairpin RNAs (shRNAs) and small interfering RNAs (siRNAs). USP18 knock-down reduced lung cancer growth, wound-healing, migration, and invasion versus controls (P < .001) and markedly decreased murine lung cancer metastases (P < .001). Reverse Phase Protein Arrays (RPPAs) in shRNA knock-down lung cancer cells showed that 14-3-3ζ protein was regulated by loss of USP18. ISG15 complexed with 14-3-3ζ protein reducing its stability. Survival in lung adenocarcinomas (P < .0015) and other cancers was linked to elevated 14-3-3ζ expression as assessed by The Cancer Genome Atlas (TCGA). The findings were confirmed and extended using 14-3-3ζ immunohistochemical assays of human lung cancer arrays and syngeneic murine lung cancer metastasis models. A direct 14-3-3ζ role in controlling lung cancer metastasis came from engineered 14-3-3ζ knock-down in lung cancer cell lines and 14-3-3ζ rescue experiments that reversed migration and invasion inhibition. Findings presented here revealed that USP18 controlled metastasis by regulating 14-3-3ζ expression. These data provide a strong rationale for developing a USP18 inhibitor to combat metastases.
first_indexed 2024-03-09T02:47:33Z
format Article
id doaj.art-89c6b8309f354ba2877fae72139376be
institution Directory Open Access Journal
issn 1538-4047
1555-8576
language English
last_indexed 2024-03-09T02:47:33Z
publishDate 2022-12-01
publisher Taylor & Francis Group
record_format Article
series Cancer Biology & Therapy
spelling doaj.art-89c6b8309f354ba2877fae72139376be2023-12-05T15:58:13ZengTaylor & Francis GroupCancer Biology & Therapy1538-40471555-85762022-12-0123126528010.1080/15384047.2022.20542422054242Loss of ubiquitin-specific peptidase 18 destabilizes 14-3-3ζ protein and represses lung cancer metastasisZibo Chen0Lin Zheng1Yulong Chen2Xiuxia Liu3Masanori Kawakami4Lisa Maria Mustachio5Jason Roszik6Katherine V. Ferry-Galow7Ralph E. Parchment8Xin Liu9Thorkell Andresson10Gerard Duncan11Jonathan M. Kurie12Jaime Rodriguez-Canales13Xi Liu14Ethan Dmitrovsky15The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterFrederick National Laboratory for Cancer ResearchThe University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterFrederick National Laboratory for Cancer ResearchFrederick National Laboratory for Cancer ResearchThe University of Texas MD Anderson Cancer CenterFrederick National Laboratory for Cancer ResearchFrederick National Laboratory for Cancer ResearchThe University of Texas MD Anderson Cancer CenterAstraZenecaThe University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterCancer metastasis is a major cause of cancer-related mortality. Strategies to reduce metastases are needed especially in lung cancer, the most common cause of cancer mortality. We previously reported increased ubiquitin-specific peptidase 18 (USP18) expression in lung and other cancers. Engineered reduction of USP18 expression repressed lung cancer growth and promoted apoptosis. This deubiquitinase (DUB) stabilized targeted proteins by removing the complex interferon-stimulated gene 15 (ISG15). This study explores if the loss of USP18 reduced lung cancer metastasis. USP18 knock-down in lung cancer cells was independently achieved using small hairpin RNAs (shRNAs) and small interfering RNAs (siRNAs). USP18 knock-down reduced lung cancer growth, wound-healing, migration, and invasion versus controls (P < .001) and markedly decreased murine lung cancer metastases (P < .001). Reverse Phase Protein Arrays (RPPAs) in shRNA knock-down lung cancer cells showed that 14-3-3ζ protein was regulated by loss of USP18. ISG15 complexed with 14-3-3ζ protein reducing its stability. Survival in lung adenocarcinomas (P < .0015) and other cancers was linked to elevated 14-3-3ζ expression as assessed by The Cancer Genome Atlas (TCGA). The findings were confirmed and extended using 14-3-3ζ immunohistochemical assays of human lung cancer arrays and syngeneic murine lung cancer metastasis models. A direct 14-3-3ζ role in controlling lung cancer metastasis came from engineered 14-3-3ζ knock-down in lung cancer cell lines and 14-3-3ζ rescue experiments that reversed migration and invasion inhibition. Findings presented here revealed that USP18 controlled metastasis by regulating 14-3-3ζ expression. These data provide a strong rationale for developing a USP18 inhibitor to combat metastases.http://dx.doi.org/10.1080/15384047.2022.2054242deubiquitinaseusp1814-3-3ζlung cancer and metastasis
spellingShingle Zibo Chen
Lin Zheng
Yulong Chen
Xiuxia Liu
Masanori Kawakami
Lisa Maria Mustachio
Jason Roszik
Katherine V. Ferry-Galow
Ralph E. Parchment
Xin Liu
Thorkell Andresson
Gerard Duncan
Jonathan M. Kurie
Jaime Rodriguez-Canales
Xi Liu
Ethan Dmitrovsky
Loss of ubiquitin-specific peptidase 18 destabilizes 14-3-3ζ protein and represses lung cancer metastasis
Cancer Biology & Therapy
deubiquitinase
usp18
14-3-3ζ
lung cancer and metastasis
title Loss of ubiquitin-specific peptidase 18 destabilizes 14-3-3ζ protein and represses lung cancer metastasis
title_full Loss of ubiquitin-specific peptidase 18 destabilizes 14-3-3ζ protein and represses lung cancer metastasis
title_fullStr Loss of ubiquitin-specific peptidase 18 destabilizes 14-3-3ζ protein and represses lung cancer metastasis
title_full_unstemmed Loss of ubiquitin-specific peptidase 18 destabilizes 14-3-3ζ protein and represses lung cancer metastasis
title_short Loss of ubiquitin-specific peptidase 18 destabilizes 14-3-3ζ protein and represses lung cancer metastasis
title_sort loss of ubiquitin specific peptidase 18 destabilizes 14 3 3ζ protein and represses lung cancer metastasis
topic deubiquitinase
usp18
14-3-3ζ
lung cancer and metastasis
url http://dx.doi.org/10.1080/15384047.2022.2054242
work_keys_str_mv AT zibochen lossofubiquitinspecificpeptidase18destabilizes1433zproteinandrepresseslungcancermetastasis
AT linzheng lossofubiquitinspecificpeptidase18destabilizes1433zproteinandrepresseslungcancermetastasis
AT yulongchen lossofubiquitinspecificpeptidase18destabilizes1433zproteinandrepresseslungcancermetastasis
AT xiuxialiu lossofubiquitinspecificpeptidase18destabilizes1433zproteinandrepresseslungcancermetastasis
AT masanorikawakami lossofubiquitinspecificpeptidase18destabilizes1433zproteinandrepresseslungcancermetastasis
AT lisamariamustachio lossofubiquitinspecificpeptidase18destabilizes1433zproteinandrepresseslungcancermetastasis
AT jasonroszik lossofubiquitinspecificpeptidase18destabilizes1433zproteinandrepresseslungcancermetastasis
AT katherinevferrygalow lossofubiquitinspecificpeptidase18destabilizes1433zproteinandrepresseslungcancermetastasis
AT ralpheparchment lossofubiquitinspecificpeptidase18destabilizes1433zproteinandrepresseslungcancermetastasis
AT xinliu lossofubiquitinspecificpeptidase18destabilizes1433zproteinandrepresseslungcancermetastasis
AT thorkellandresson lossofubiquitinspecificpeptidase18destabilizes1433zproteinandrepresseslungcancermetastasis
AT gerardduncan lossofubiquitinspecificpeptidase18destabilizes1433zproteinandrepresseslungcancermetastasis
AT jonathanmkurie lossofubiquitinspecificpeptidase18destabilizes1433zproteinandrepresseslungcancermetastasis
AT jaimerodriguezcanales lossofubiquitinspecificpeptidase18destabilizes1433zproteinandrepresseslungcancermetastasis
AT xiliu lossofubiquitinspecificpeptidase18destabilizes1433zproteinandrepresseslungcancermetastasis
AT ethandmitrovsky lossofubiquitinspecificpeptidase18destabilizes1433zproteinandrepresseslungcancermetastasis